Moxonidine-impurities | Pharmaffiliates

moxonidine

Moxonidine is a new-generation centrally acting antihypertensive drug, which is approved for the treatment of mild to moderate essential hypertension. moxonidine has been shown to present blood pressure-independent beneficial effects on insulin resistance syndrome. Reference standards of Moxonidine API,and its pharmacopeial, non pharmacopeial impurities, and stable isotopes are listed below.

stdClass Object
(
    [pname] => Moxonidine impurity A (Y0000222)
    [catalogue_number] => PA EPY0000222
    [category_ids] => ,150,
    [chemical_name] => 
    [weight] => NA
    [form] => NA
    [cas] => NA
    [pslug] => moxonidine-impurity-a-y0000222-paepy0000222
    [latest_product] => 0
    [linkproducts] => 0
    [offers_id] => 
    [offers_name] => 
    [offers_status] => 
    [offers_start_date] => 
    [offers_end_date] => 
    [pageview] => 
    [offers_slug] => 
    [offers_product_id] => 
    [offers_product_code] => 
    [offers_master_id] => 
    [offer_percentage] => 
    [offers_product_main_cat] => 
)

Moxonidine impurity A (Y0000222)


  • Catalogue No.:PA EPY0000222

  • CAS :

    NA

  • Molecular Formula : NA

  • Molecular Weight : NA

stdClass Object
(
    [pname] => Moxonidine (Y0000226)
    [catalogue_number] => PA EPY0000226
    [category_ids] => ,150,
    [chemical_name] => 
    [weight] => NA
    [form] => NA
    [cas] => NA
    [pslug] => moxonidine-y0000226-paepy0000226
    [latest_product] => 0
    [linkproducts] => 0
    [offers_id] => 
    [offers_name] => 
    [offers_status] => 
    [offers_start_date] => 
    [offers_end_date] => 
    [pageview] => 
    [offers_slug] => 
    [offers_product_id] => 
    [offers_product_code] => 
    [offers_master_id] => 
    [offer_percentage] => 
    [offers_product_main_cat] => 
)

Moxonidine (Y0000226)


  • Catalogue No.:PA EPY0000226

  • CAS :

    NA

  • Molecular Formula : NA

  • Molecular Weight : NA